The next-generation sequencing (NGS)-based multiplex companion diagnostic (CDx) test simultaneously evaluates patient tumor samples for biomarkers associated with targeted therapies for non-small cell lung cancer (NSCLC). Oncomine Dx
The post Thermo Fisher’s Oncomine Dx target test receives expanded regulatory approval in Japan appeared first on Compelo Medical Devices.